AIDS Prevention

Los Alamos researchers recommend AIDS vaccine strategies

Published in Medical Letter on the CDC and FDA, August 18th, 2002

Researchers at the U.S. Department of Energy's (DOE) Los Alamos National Laboratory are using their extensive genetic understanding of the HIV-1 virus - the most common form of the virus that causes AIDS in humans - to consider best strategies in the pursuit of creating a vaccine to fight the virus.

In an article appearing recently in the journal Science, a team of Los Alamos researchers - in conjunction with researchers from Duke University, Harvard School of Public Health and the University of Alabama - suggests using a consensus or genetic ancestor of the HIV-1 virus when developing vaccines, rather than basing vaccines on geographically specific strains of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-08-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry